The Impact of the Reengineering Processes on Critical Performance Measures: A Comparative Study between Pharmaceutical and Chemical Companies in Jordan
Keywords:
Reengineering Processes, Order Flow Processes, Products Production Processes, Human Resources Processes, Marketing Processes, Products Development Processes, Financial Processes, Logistics and Warehousing Processes, Critical Performance Measures, PharmaceAbstract
The aim of this study is to investigate the effect of reengineering
processes on the critical performance measures of pharmaceutical and
chemical industry in Jordan, from the viewpoint of the respondents in both
sectors. In order to achieve the goal of the study, and test its hypotheses, the
researchers have developed a questionnaire to collect data from managers
and chiefs of departments in the researched companies. The researchers have
distributed (250) questionnaires, and collected (158) , forming a response
rate of (63.2%) .
Multiple Regression Analysis was used to test the effect of independent
variables that represent the reengineering processes (order flow, products
production, human resources, marketing, products development, financial,
and logistics and warehousing) on the dependent variable that represent
critical performance measures of those companies (quality, time, and cost)
. The researchers also used (t- test) for independent samples to examine
differences between the pharmaceutical and chemical industry in the
reengineering processes and critical performance measures.
The most important results of the study are:
1. There is a statistical significant impact at a level (a= 0.05) of reengineering
order flow processes, and human resources processes on critical
performance measures in Pharmaceutical industry sector.
2. There is a statistical significant impact at a level (a= 0.05) of reengineering
order flow processes, financial processes, and logistics and warehousing
processes on critical performance measures in Chemical industry sector.
3. There is a statistical significance difference at the level of significance
(a= 0.05) of reengineering processes and critical performance measures
depending on the type of industry (pharmaceutical, chemical) and the
result was in favor of the pharmaceutical sector.
Based upon these results, a number of recommendations are proposed to
enhance the role of reengineering processes in order to improve the level of
critical performance measures.
Downloads
Published
How to Cite
Issue
Section
License
- The editorial board confirms its commitment to the intellectual property rights
- Researchers also have to commit to the intellectual property rights.
- The research copyrights and publication are owned by the Journal once the researcher is notified about the approval of the paper. The scientific materials published or approved for publishing in the Journal should not be republished unless a written acknowledgment is obtained by the Deanship of Scientific Research.
- Research papers should not be published or republished unless a written acknowledgement is obtained from the Deanship of Scientific Research.
- The researcher has the right to accredit the research to himself, and to place his name on all the copies, editions and volumes published.
- The author has the right to request the accreditation of the published papers to himself.